{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T17:26:32Z","timestamp":1783617992601,"version":"3.55.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T00:00:00Z","timestamp":1532044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10,1]]},"DOI":"10.1093\/ajcp\/aqy076","type":"journal-article","created":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T03:17:14Z","timestamp":1529032634000},"page":"375-384","source":"Crossref","is-referenced-by-count":16,"title":["The Utilization of Chromosomal Microarray Technologies for Hematologic Neoplasms"],"prefix":"10.1093","volume":"150","author":[{"given":"Jess F","family":"Peterson","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Division of Laboratory Genetics and Genomics, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L","family":"Van Dyke","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Division of Laboratory Genetics and Genomics, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole L","family":"Hoppman","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Division of Laboratory Genetics and Genomics, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hutton M","family":"Kearney","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Division of Laboratory Genetics and Genomics, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R","family":"Sukov","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Division of Laboratory Genetics and Genomics, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia T","family":"Greipp","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Division of Laboratory Genetics and Genomics, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhett P","family":"Ketterling","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Division of Laboratory Genetics and Genomics, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda B","family":"Baughn","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Division of Laboratory Genetics and Genomics, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,7,20]]},"reference":[{"key":"key\n\t\t\t\t20181001110224_CIT0001","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2017","edition":"Revised 4th ed"},{"key":"key\n\t\t\t\t20181001110224_CIT0002","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood-2017-02-734541","article-title":"Diagnosis and classification of hematologic malignancies on the basis of genetics","volume":"130","author":"Taylor","year":"2017","journal-title":"Blood"},{"key":"key\n\t\t\t\t20181001110224_CIT0003","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev-genom-090413-025346","article-title":"Detection of chromosomal aberrations in clinical practice: from karyotype to genome sequence","volume":"16","author":"Martin","year":"2015","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"key\n\t\t\t\t20181001110224_CIT0004","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/GIM.0b013e3181f8baad","article-title":"Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities","volume":"12","author":"Manning","year":"2010","journal-title":"Genet Med"},{"key":"key\n\t\t\t\t20181001110224_CIT0005","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.gde.2012.01.005","article-title":"The use of new technologies in the detection of balanced translocations in hematologic disorders","volume":"22","author":"Shaffer","year":"2012","journal-title":"Curr Opin Genet Dev"},{"key":"key\n\t\t\t\t20181001110224_CIT0006","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1373\/clinchem.2014.227785","article-title":"Detection of clonal evolution in hematopoietic malignancies by combining comparative genomic hybridization and single nucleotide polymorphism arrays","volume":"60","author":"Hartmann","year":"2014","journal-title":"Clin Chem"},{"key":"key\n\t\t\t\t20181001110224_CIT0007","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"key":"key\n\t\t\t\t20181001110224_CIT0008","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/ajh.24253","article-title":"Myelodysplastic syndromes: contemporary review and how we treat","volume":"91","author":"Gangat","year":"2016","journal-title":"Am J Hematol"},{"key":"key\n\t\t\t\t20181001110224_CIT0009","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cancergen.2011.10.004","article-title":"Microarray-based comparative genomic hybridization of cancer targets reveals novel, recurrent genetic aberrations in the myelodysplastic syndromes","volume":"204","author":"Kolquist","year":"2011","journal-title":"Cancer Genet"},{"key":"key\n\t\t\t\t20181001110224_CIT0010","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1182\/blood-2010-07-295857","article-title":"Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies","volume":"117","author":"Tiu","year":"2011","journal-title":"Blood"},{"key":"key\n\t\t\t\t20181001110224_CIT0011","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/leu.2010.293","article-title":"Comprehensive array CGH of normal karyotype myelodysplastic syndromes reveals hidden recurrent and individual genomic copy number alterations with prognostic relevance","volume":"25","author":"Thiel","year":"2011","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20181001110224_CIT0012","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/gcc.22112","article-title":"Single nucleotide polymorphism array karyotyping: a diagnostic and prognostic tool in myelodysplastic syndromes with unsuccessful conventional cytogenetic testing","volume":"52","author":"Arenillas","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"key\n\t\t\t\t20181001110224_CIT0013","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/gcc.22455","article-title":"Genomic array as compared to karyotyping in myelodysplastic syndromes in a prospective clinical trial","volume":"56","author":"Stevens-Kroef","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"key":"key\n\t\t\t\t20181001110224_CIT0014","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1309\/AJCPAN7BH5DNYWZB","article-title":"B-acute lymphoblastic leukemia\/lymphoblastic lymphoma","volume":"144","author":"Loghavi","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t20181001110224_CIT0015","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nrclinonc.2015.38","article-title":"Genomics in acute lymphoblastic leukaemia: insights and treatment implications","volume":"12","author":"Roberts","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"key\n\t\t\t\t20181001110224_CIT0016","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.anndiagpath.2016.02.002","article-title":"Advances in B-lymphoblastic leukemia: cytogenetic and genomic lesions","volume":"23","author":"Zhou","year":"2016","journal-title":"Ann Diagn Pathol"},{"key":"key\n\t\t\t\t20181001110224_CIT0017","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1200\/JCO.2016.70.7836","article-title":"Genetic basis of acute lymphoblastic leukemia","volume":"35","author":"Iacobucci","year":"2017","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20181001110224_CIT0018","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1470-2045(10)70066-8","article-title":"Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97\/99 randomised trial","volume":"11","author":"Moorman","year":"2010","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t20181001110224_CIT0019","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1182\/blood-2014-03-562918","article-title":"A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia","volume":"124","author":"Moorman","year":"2014","journal-title":"Blood"},{"key":"key\n\t\t\t\t20181001110224_CIT0020","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2141.2004.04948.x","article-title":"Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia","volume":"125","author":"Harrison","year":"2004","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t20181001110224_CIT0021","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1182\/blood-2006-07-038299","article-title":"Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia","volume":"110","author":"Nachman","year":"2007","journal-title":"Blood"},{"key":"key\n\t\t\t\t20181001110224_CIT0022","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/gcc.22163","article-title":"Acute lymphoblastic leukemia with low hypodiploid\/near triploid karyotype is a specific clinical entity and exhibits a very high TP53 mutation frequency of 93%","volume":"53","author":"M\u00fchlbacher","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"key\n\t\t\t\t20181001110224_CIT0023","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/leu.2013.317","article-title":"An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome","volume":"28","author":"Harrison","year":"2014","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20181001110224_CIT0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergen.2014.11.003","article-title":"Integration of cyto genomic data for furthering the characterization of pediatric B-cell acute lymphoblastic leukemia: a multi-institution, multi-platform microarray study","volume":"208","author":"Baughn","year":"2015","journal-title":"Cancer Genet"},{"key":"key\n\t\t\t\t20181001110224_CIT0025","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1056\/NEJMoa0808253","article-title":"Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia","volume":"360","author":"Mullighan","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20181001110224_CIT0026","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1038\/leu.2015.134","article-title":"IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children\u2019s Leukemia Group Study 58951","volume":"29","author":"Clappier","year":"2015","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20181001110224_CIT0027","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.leukres.2017.01.034","article-title":"Genomic analysis of adult B-ALL identifies potential markers of shorter survival","volume":"56","author":"Patel","year":"2017","journal-title":"Leuk Res"},{"key":"key\n\t\t\t\t20181001110224_CIT0028","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1182\/blood-2012-10-462358","article-title":"Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL","volume":"122","author":"van der Veer","year":"2013","journal-title":"Blood"},{"key":"key\n\t\t\t\t20181001110224_CIT0029","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia","volume":"343","author":"D\u00f6hner","year":"2000","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20181001110224_CIT0030","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1038\/onc.2012.411","article-title":"The biology and clinical significance of acquired genomic copy number aberrations and recurrent gene mutations in chronic lymphocytic leukemia","volume":"32","author":"Malek","year":"2013","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20181001110224_CIT0031","doi-asserted-by":"crossref","first-page":"435983","DOI":"10.1155\/2014\/435983","article-title":"Genetic abnormalities in chronic lymphocytic leukemia: where we are and where we go","volume":"2014","author":"Puiggros","year":"2014","journal-title":"Biomed Res Int"},{"key":"key\n\t\t\t\t20181001110224_CIT0032","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.3324\/haematol.2010.039768","article-title":"Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia","volume":"96","author":"Gunnarsson","year":"2011","journal-title":"Haematologica"},{"key":"key\n\t\t\t\t20181001110224_CIT0033","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.cancergen.2011.10.012","article-title":"Clonal diversity analysis using SNP microarray: a new prognostic tool for chronic lymphocytic leukemia","volume":"204","author":"Zhang","year":"2011","journal-title":"Cancer Genet"},{"key":"key\n\t\t\t\t20181001110224_CIT0034","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2353\/jmoldx.2008.080033","article-title":"Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia","volume":"10","author":"Gunn","year":"2008","journal-title":"J Mol Diagn"},{"key":"key\n\t\t\t\t20181001110224_CIT0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2353\/jmoldx.2009.080037","article-title":"Customized oligonucleotide array-based comparative genomic hybridization as a clinical assay for genomic profiling of chronic lymphocytic leukemia","volume":"11","author":"Sargent","year":"2009","journal-title":"J Mol Diagn"},{"key":"key\n\t\t\t\t20181001110224_CIT0036","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s12032-010-9614-0","article-title":"Partial trisomy 11, dup(11)(q23q13), as a defect characterizing lymphomas with Burkitt pathomorphology without MYC gene rearrangement","volume":"28","author":"Pienkowska-Grela","year":"2011","journal-title":"Med Oncol"},{"key":"key\n\t\t\t\t20181001110224_CIT0037","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1182\/blood-2013-06-507996","article-title":"A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma","volume":"123","author":"Salaverria","year":"2014","journal-title":"Blood"},{"key":"key\n\t\t\t\t20181001110224_CIT0038","doi-asserted-by":"crossref","first-page":"1926304","DOI":"10.1155\/2017\/1926304","article-title":"The utilization of formalin fixed-paraffin-embedded specimens in high throughput genomic studies","volume":"2017","author":"Zhang","year":"2017","journal-title":"Int J Genomics"},{"key":"key\n\t\t\t\t20181001110224_CIT0039","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/gim.2013.49","article-title":"American College of Medical Genetics and Genomics technical standards and guidelines: microarray analysis for chromosome abnormalities in neoplastic disorders","volume":"15","author":"Cooley","year":"2013","journal-title":"Genet Med"},{"key":"key\n\t\t\t\t20181001110224_CIT0040","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/gcc.22350","article-title":"Guidelines for genomic array analysis in acquired haematological neoplastic disorders","volume":"55","author":"Schoumans","year":"2016","journal-title":"Genes Chromosomes Cancer"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/150\/5\/375\/25883277\/aqy076.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T13:14:41Z","timestamp":1571490881000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/150\/5\/375\/5056501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,20]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,7,20]]},"published-print":{"date-parts":[[2018,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ajcp\/aqy076","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,11]]},"published":{"date-parts":[[2018,7,20]]}}}